Bertin L, Savarino V, Marabotto E, Ghisa M, de Bortoli N, Savarino EV: Pathophysiology of Gastroesophageal Reflux Disease. Digestion 2025:1–17.
Fass R, Gasiorowska A. Refractory GERD: what is it? Curr Gastroenterol Rep. 2008;10(3):252–7.
Jang Y, Park J, Kang D, Kim JH, Choi HS, Jeon HL, Lee H: Safety of Potassium-Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta-Analysis. J Gastroenterol Hepatol 2026;41(1):28–40.
Gadalla EAY, El Serafy ME, El Din Abd El Monaem AH, El Sayed EA, Abdalla AKM. Comparative study between the effect of Nissen fundoplication and Toupet fundoplication on postoperative manometry findings. A randomized control trial study. Surg Endosc. 2025;39(11):7281–91.
Article PubMed PubMed Central Google Scholar
Skubleny D, Switzer NJ, Dang J, Gill RS, Shi X, de Gara C, Birch DW, Wong C, Hutter MM, Karmali S. LINX(®) magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis. Surg Endosc. 2017;31(8):3078–84.
Broeders JA, Roks DJ, Ahmed Ali U, Watson DI, Baigrie RJ, Cao Z, Hartmann J, Maddern GJ. Laparoscopic anterior 180-degree versus nissen fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis of randomized clinical trials. Ann Surg. 2013;257(5):850–9.
Stephan D, Borbely Y, Schoppmann SF. RefluxStop™ Therapy - a New Minimally Invasive Technology in Anti-reflux Surgery. Surg Technol Int. 2022;41:137–42.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.
Article PubMed PubMed Central Google Scholar
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.
Elshafei M. Experience With an Innovative Surgical Treatment Option for Gastroesophageal Reflux Disease: Results of 28 Patients in a Retrospective Analysis. J Laparoendosc Adv Surg Tech A. 2025;35(5):357–64.
Lehmann T, Šimkus M, Oehler C. A retrospective study assessing RefluxStop surgery for gastroesophageal reflux disease: Clinical outcomes in 79 patients from Germany. Surg Open Sci. 2025;23:9–15.
Zehetner J, Niebuhr N, Linas I, Kessler U, Fringeli Y. Laparoscopic antireflux surgery with the RefluxStop implant for severe sufferers with complex disease: a retrospective study of the first 100 patients with 12-month follow-up at an early adopter institution. J Gastrointest Surg. 2025;30(2)102293.
Harsányi L, Kincses Z, Veselinović M, Zehetner J, Altorjay Á. Five-year clinical outcomes of RefluxStop surgery in the treatment of acid reflux: a prospective multicenter trial of safety and effectiveness. Surg Endosc. 2025;39(9):6163–79.
Article PubMed PubMed Central Google Scholar
Borbély Y, Kroell D, Gerber S, Fringeli Y, Linas I, Zehetner J. A safety and effectiveness evaluation of refluxstop in the treatment of acid reflux comparing large and small hiatal hernia groups: results from 99 patients in Switzerland with up to 4‑years follow-up. Hernia. 2025;29(1)156.
Article PubMed PubMed Central Google Scholar
Fringeli Y, Linas I, Kessler U, Zehetner J. Laparoscopic Large Hiatal Hernia Repair With RefluxStop: Outcomes of Six Months Follow-up in Thirty Patients. Surg Laparosc Endosc Percutan Tech. 2024;34(2):143–9.
Article PubMed PubMed Central Google Scholar
Feka J, Saad M, Boyle N, Paireder M, Kristo I, Rieder E, Asari R, Schoppmann SF. Multicentric short term and safety study of ineffective esophageal motility patients treated with RefluxStop device. Sci Rep. 2024;14(1)15425.
Article CAS PubMed PubMed Central Google Scholar
Fringeli Y, Linas I, Kessler U, Zehetner J. Short-term results of laparoscopic anti-reflux surgery with the RefluxStop device in patients with gastro-esophageal reflux disease and ineffective esophageal motility. Langenbecks Arch Surg. 2024;409(1)78.
Article PubMed PubMed Central Google Scholar
Fringeli Y, Linas I, Kessler U, Zehetner J. Exploring the feasibility and safety of laparoscopic anti-reflux surgery with the new RefluxStop™ device: a retrospective cohort study of 40 patients. Swiss Med Wkly. 2024;154:3365.
Harsányi L, Kincses Z, Veselinovic M, Zehetner J, Altorjay A. Food passageway-related sequelae in the RefluxStop prospective multicenter trial: patient-centric outcomes of dysphagia, odynophagia, gas-bloating, and inability to belch and/or vomit at 5 years. Surgical Endoscopy and Other Interventional Techniques. 2025;39(7):4615–27.
Article PubMed PubMed Central Google Scholar
Harper S, Kartha M, Mealing S, Lundell L. A cost-effectiveness analysis of RefluxStop against relevant therapeutic alternatives for chronic gastroesophageal reflux disease in Sweden. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2025;25(3):353–65.
Harper S, Grodzicki L, Mealing S, Gemmill L, Goldsmith PJ, Ahmed AR. Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease. J Med Econ. 2023;26(1):603–13.
Harper S, Kartha M, Mealing S, Eftang L, Gaupset R. Cost-effectiveness of RefluxStop compared to proton pump inhibitors and Nissen fundoplication for management of persistent gastroesophageal reflux disease in Norway. Cost Eff Resour Alloc. 2025;23(1):63–63.
Article PubMed PubMed Central Google Scholar
Harper S, Kartha M, Mealing S, Borbély YM, Zehetner J. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland. J Med Econ. 2024;27(1):805–15.
Harper S, Grodzicki L, Mealing S, Gemmill E, Goldsmith P, Ahmed A. Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom. J Health Econ Outcomes Res. 2024;11(1):1–7.
Article PubMed PubMed Central Google Scholar
Harper S, Kartha M, Mealing S, Pavanello M, Bonavina L. The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System. Pharmacoecon Open. 2024;8(6):935–43.
Article PubMed PubMed Central Google Scholar
Elshafei M, Aiolfi A, Bonitta G, Bona D, Bonavina L. Learning Curve of the Laparoscopic RefluxStop Procedure for the Treatment of Gastroesophageal Reflux Disease. J Laparoendosc Adv Surg Tech A. 2025;35(11):849–55.
Bjelović M, Harsányi L, Altorjay Á, Kincses Z, Forsell P. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1‑year results : RefluxStop™ device; a new method in acid reflux surgery obtaining CE mark. BMC Surg. 2020;20(1)159.
Article PubMed PubMed Central Google Scholar
Lee Y, Tahir U, Tessier L, Yang K, Hassan T, Dang J, Kroh M, Hong D. Long-term outcomes following Dor, Toupet, and Nissen fundoplication: a network meta-analysis of randomized controlled trials. Surg Endosc. 2023;37(7):5052–64.
German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). S2k guideline Gastroesophageal reflux disease and eosinophilic esophagitis of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). Z Gastroenterol. 2024;62(10):1786–852.
Markar S, Andreou A, Bonavina L, Florez ID, Huo B, Kontouli KM, Low DE, Mavridis D, Maynard N, Moss A, et al. UEG and EAES rapid guideline: Update systematic review, network meta-analysis, CINeMA and GRADE assessment, and evidence-informed European recommendations on surgical management of GERD. United European Gastroenterol J. 2022;10(9):983–98.
Article PubMed PubMed Central Google Scholar
Watson DI, Thompson SK, Devitt PG, Aly A, Irvine T, Woods SD, Gan S, Game PA, Jamieson GG. Five Year Follow-up of a Randomized Controlled Trial of Laparoscopic Repair of Very Large Hiatus Hernia With Sutures Versus Absorbable Versus Nonabsorbable Mesh. Ann Surg. 2020;272(2):241–7.
Harper S, Kartha M, Mealing S, Lundell L: A cost-effectiveness analysis of RefluxStop against relevant therapeutic alternatives for chronic gastroesophageal reflux disease in Sweden. Expert Rev Pharmacoecon Outcomes Res 2024:1–13.
A Blinded Randomized Clinical Investigation of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of Gastroesophageal Reflux Disease (GERD). ClinicalTrials.gov:NCT07004400.https://www.embase.com/records?id=LNCT07004400
A Post-market Registry Study Based on Standard Clinical Care to Assess Safety and Performance of RefluxStop™ in the Treatment of Gastroesophageal Reflux Disease (GERD) in General Hospital Practice. ClinicalTrials.gov:NCT07004439.https://www.embase.com/records?id=LNCT07004439
Comments (0)